<DOC>
	<DOCNO>NCT02741167</DOCNO>
	<brief_summary>The purpose study ass dynamic inflammatory parameter presence absence infectious complication cytoreductive surgery hyperthermic intraperitoneal chemotherapy .</brief_summary>
	<brief_title>Pathophysiology Inflammation After Cytoreductive Surgery Hyperthermic Intraperitoneal Chemotherapy</brief_title>
	<detailed_description>Cytoreductive surgery hyperthermic intraperitoneal chemotherapy treatment choice patient primary secondary peritoneal surface malignancy . However survival benefit achieve cost increase morbidity mortality due extensive surgery intraoperative chemo-therapy . Among complication infectious complication common . The early diagnosis potential fatal infection therefore crucial ensure good outcome patient .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Fever</mesh_term>
	<criteria>Consecutive adult patient ( 18 year ) subject CRS HIPEC due peritoneal malignancy . Written inform consent participant information research project No primary secondary peritoneal surface malignancy No CRS HIPEC Pregnancy Younger 18 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>peritoneal surface malignancy</keyword>
	<keyword>cytoreductive surgery</keyword>
	<keyword>hyperthermic intraperitoneal chemotherapy</keyword>
</DOC>